and their
binding sites, noncoding RNAs and their targets in protein-coding gene sequences evolutionarily originated
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) RNA
binding site with the risk of developing clear cell renal cell carcinoma (ccRCC). As a result
FACHAL, L.,
KAR, S.,
TYRER, J.P.,
GHOUSSAINI, M.,
HARRINGTON, P.A.,
HEALEY, C.S.,
MAYES, R.,
SHAH, M.,
PHAROAH, P.D.P.,
EASTON, D.F.,
DUNNING, A.M.,
ASCHARD, H.,
JIANG, X.,
TAMIMI, R.M.,
KHUSNUTDINOVA, E.,
BIAŁKOWSKA, K.,
и др. соавторы (2020) significantly over-represented in active gene regulatory regions and transcription factor
binding sites. We
CAI, B.,
MA, W.,
WANG, X.,
SUKHAREVA, N.,
HUA, B.,
ZHANG, L.,
LI, X.,
LI, S.,
LIU, S.,
YU, M.,
XU, Y.,
SONG, R.,
XU, B.,
YANG, F.,
HAN, Z.,
DING, F.,
HUANG, Q.,
YU, Y.,
ZHAO, Y.,
WANG, J.,
BAMBA, D.,
PAN, Z.,
YANG, B.,
XU, J.,
ZAGIDULLIN, N.,
LI, F.,
TIAN, Y. (2020) to directly
bind to protein phosphatase 1 catalytic subunit alpha (PP1A), and in turn, limit its
isolated from a microorganism. It was shown to be a specific inhibitor that directly
bindsDAVYDOVA, YU. D.,
KAZANTSEVA, A. V.,
ENIKEEVA, R. F.,
MUSTAFIN, R.N.,
ENIKEEVA, R. F.,
LOBASKOVA, M. M.,
MALYKH, S. B.,
GILYAZOVA, I.R.,
KHUSNUTDINOVA, E.K. (2020) its
binding to oxytocin receptor (OXTR). Considering the multifactorial nature of developing